Physician profile
Stephanie D Dailey
NPI 1790717767
$2,748.60
in general payments reported to CMS, 2019-2025
9 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.14 · 2022: $33.57 · 2023: $2,468 · 2024: $63.79 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,937 · Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,937.04 |
| Food and Beverage | $719.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $2,443.53 | 2023 | |
| Travere Therapeutics, INC. | $124.99 | 2025 | Filspari |
| Otsuka America Pharmaceutical, INC. | $48.11 | 2022-2024 | Jynarque |
| Celgene Corporation | $44.73 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $24.58 | 2023 | |
| Scpharmaceuticals INC. | $18.99 | 2024 | |
| Janssen Pharmaceuticals, INC | $15.34 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.92 | 2024 | Lokelma |
| Vifor Pharma, INC. | $13.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Dailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.